Latest Breaking News On - Celltrion inhalon - Page 1 : comparemela.com

Celltrion submitted an IND application for a global Phase III clinical trial of inhaled antibody cocktail therapy with CT-P59 and CT-P63; the company expects to enrol 2,200 patients with mild-to-moderate

Kostenloser wertpapierhandelCelltrion inhalonDonna curranInhalon biopharmaEuropean medicines agencyCelltrion groupCommittee for medicinal products human useMarketing division at celltrion healthcareTherapeutic goods administrationInvestigational new drugHoung kimMarketing divisionConfidential disclosureMaterial transfer agreementMedicinal productsHuman use